Inventor

STAUFFER SHAUN R

US38 patents

⚠️ This page may combine multiple inventors who share the name “STAUFFER SHAUN R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

STAUFFER SHAUN R

UNIV VANDERBILT

WDR5 inhibitors and modulators

WDR5 inhibitors and modulators

Substituted quinazolin-4(3H)-ones, pyrido[3,4-d]pyrimidin-4(3H)-ones, pyrido[3,2-d]pyrimidin-4(3H)-ones and pyrido[2,3-d]pyrimidin-4(3H)-ones as positive allosteric modulators of muscarinic acetycholine receptor M1

WDR5 inhibitors and modulators

WDR5-MLL1 inhibitors and modulators

WDR5 inhibitors and modulators

Substituted 4-benzyl-3,4-dihydro-2H-benzo[B][1,4]oxazine-2-carboxamide analogs as positive allosteric modulators of muscarinic acetycholine receptor M1

Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1

Substituted pyrazolo[1,5-a]pyrazines as mGluR5 receptor modulators

Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors

Substituted bicyclic alkoxy pyrazole analogs as allosteric modulators of mGluR5 receptors

WDR5-MYC inhibitors

Substituted indoles as selective protease activated receptor 4 (PAR-4) antagonists

WDR5-MYC inhibitors

Substituted 5-membered heterocyclic analogs as protease activated receptor 4 (PAR-4) antagonists

CONN P JEFFREY

Bicyclic triazole and pyrazole lactams as allosteric modulators of mGluR5 receptors

Dihydronaphthyridinyl(organo)methanone analogs as positive allosteric mGluR5 modulators

Substituted pyrazolo[1,5-A]pyrazine compounds as allosteric modulators of mGluR5 receptors

Bicyclic oxazole and thiazole compounds and their use as allosteric modulators of mGluR5 receptors

Substituted imidazopyrimidin-5(6H)-ones as allosteric modulators of MGLUR5 receptors

Naphthyridinone analogs as mGluR5 positive allosteric modulators

Substituted 6-methylnicotinamides as mGluR5 positive allosteric modulators

MERCK SHARP & DOHME

Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer&#39;s Disease

Aminomethyl beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

MERCK & CO INC

Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

NANTERMET PHILIPPE G

Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

STAUFFER SHAUN R

Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

UNIV MICHIGAN

Menin-MLL inhibitors and methods of use thereof

BURGEY CHRISTOPHER S

P2X3 receptor antagonists for treatment of pain

MCGAUGHEY GEORGIA B

Tertiary carbinamines having substituted heterocycles which are active as β-secretase inhibitors for the treatment of alzheimer&#39;s disease

COBURN CRAIG A

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

CLEVELAND CLINIC FOUND

Allosteric activators of the ALPHA1A-adrenergic receptor

BARROW JAMES C

Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer&#39;s disease

MERCK SHARP & DOHME INC

1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer&#39;s disease

Bicyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease

2,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's Disease

Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease

Benzylether and benzylamino beta-secretase inhibitors for the treatment of Alzheimer's disease

Phenylamide and pyridylamide beta-secretase inhibitors for the treatment of Alzheimer's disease

Macrocyclic spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's disease

2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease

Piperidine and pyrrolidine beta-secretase inhibitors for the treatment of alzheimer's disease

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Tertiary carbinamines having substituted heterocycles which are active as β-secretase inhibitors for the treatment of alzheimer's disease

Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease

Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease

1,3,5-substituted phenyl derivative compounds useful as beta-secretase inhibitors for the treatment of Alzheimer's disease